Liang-Chuan Wang

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors

Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi et al. · Clinical Cancer Research · 2014 · 402 citations · Full text

Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery

Jarrod D. Predina, Evgeniy Eruslanov, Brendan F. Judy et al. · Proceedings of the National Academy of Sciences · 2012 · 189 citations · Full text

Mesothelin, a novel immunotherapy target for triple negative breast cancer

Julia Tchou, Liang-Chuan Wang, Ben Selven et al. · Breast Cancer Research and Treatment · 2012 · 178 citations · Full text

Breast Oncology, Immunology, Immune Checkpoint Inhibitor +7

Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Enxiu Wang, Liang-Chuan Wang, Ching‐Yi Tsai et al. · Cancer Immunology Research · 2015 · 111 citations · Full text

Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo

Sarah A. Richman, Liang-Chuan Wang, Edmund K. Moon et al. · Molecular Therapy · 2020 · 77 citations · Full text